When we feed the body correctly, we can influence the same systems that drugs like Mounjaro target - helping regulate ...

India is among the top two countries in terms of type 2 diabetes cases and third in terms of obesity; hence, the need for ...

An estimated 1.5 million Britons are now using wonder drugs such as Ozempic, Mounjaro or Wegovy. But new research suggests it ...

As weight-loss injections like Mounjaro and Wegovy soar in popularity across the UK, jewellers say they’re seeing an unexpected side effect: wedding and engagement rings no longer fit, and in they are ...

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

GLP-1 weight loss patches are everywhere but do they actually work as these trendy patches promise Ozempic-like results ...

FAT jabs are ruining dinner parties as guests on weight-loss drugs lose their appetites. A survey found one in three hosts ...

NVO is expanding into rare blood disorders like hemophilia to ease reliance on GLP-1 drugs Ozempic and Wegovy.

A University of Dundee spin-out has formed a new company dedicated to developing new obesity therapies that avoid the muscle ...

Viking Therapeutics (VKTX 1.70%) is developing VK2735, a dual GLP-1/GIP receptor agonist for obesity treatment. The company ...

There are some potential downsides though, including misuse by those who do not need to lose weight, some gastric side-effects and in limited cases, potentially pancreatitis and gall bladder disorders ...

Eli Lilly & Company (NYSE:LLY) ranks among the best set-it-and-forget-it stocks to buy. On June 27, UBS kept its Buy rating ...